Physician profile
Brian G Comer
NPI 1538155205
$3,222.38
in general payments reported to CMS, 2019-2025
38 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $647 · 2020: $622 · 2021: $308 · 2022: $478 · 2023: $441 · 2024: $575 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $309.18 | 2019-2024 | Vraylar, Viberzi, Linzess |
| Sanofi-Aventis U.S. LLC | $274.03 | 2019-2023 | |
| Novo Nordisk INC | $261.75 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $235.40 | 2021-2024 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $218.32 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $197.72 | 2020-2024 | Jardiance, Mounjaro |
| Merck Sharp & Dohme LLC | $153.19 | 2019-2024 | Belsomra, Gardasil 9, Gardasil |
| Pfizer INC. | $138.36 | 2019-2025 | |
| Agios Pharmaceuticals, INC. | $129.20 | 2022-2024 | Pyrukynd |
| Janssen Pharmaceuticals, INC | $107.62 | 2019-2022 | |
| Abbott Laboratories | $104.50 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $101.33 | 2024 | Takhzyro, Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.30 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $91.67 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $90.77 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Comer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.